Remove Bioavailability Remove Containment Remove Gene Silencing Remove Production
article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 Furthermore, the bioavailability of the active pharmaceutical ingredient (API) into the cornea is up to four times stronger with EyeSol technology.